| amine metabolic process | GO:0009308 | 45 | 0.280 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.252 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.241 | |
| muscle tissue development | GO:0060537 | 308 | 0.146 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.146 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.133 | |
| neuronal action potential | GO:0019228 | 54 | 0.131 | |
| camera type eye development | GO:0043010 | 266 | 0.113 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.107 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.107 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.094 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.091 | |
| protein catabolic process | GO:0030163 | 221 | 0.090 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.085 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.085 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.084 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.083 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.076 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.073 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.071 | |
| male sex differentiation | GO:0046661 | 109 | 0.070 | |
| urogenital system development | GO:0001655 | 261 | 0.070 | |
| ear development | GO:0043583 | 200 | 0.069 | |
| circulatory system process | GO:0003013 | 197 | 0.067 | |
| cell maturation | GO:0048469 | 127 | 0.067 | |
| extracellular structure organization | GO:0043062 | 148 | 0.064 | |
| intracellular protein transport | GO:0006886 | 204 | 0.064 | |
| respiratory system development | GO:0060541 | 190 | 0.064 | |
| stem cell differentiation | GO:0048863 | 268 | 0.064 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.063 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.063 | |
| response to growth factor | GO:0070848 | 198 | 0.062 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.062 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.062 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.061 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.061 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.060 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.060 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.060 | |
| cognition | GO:0050890 | 149 | 0.059 | |
| action potential | GO:0001508 | 78 | 0.059 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.057 | |
| stem cell development | GO:0048864 | 219 | 0.057 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.057 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.056 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.056 | |
| ossification | GO:0001503 | 216 | 0.056 | |
| cerebellum development | GO:0021549 | 77 | 0.054 | |
| skeletal system development | GO:0001501 | 356 | 0.052 | |
| cytokine production | GO:0001816 | 319 | 0.052 | |
| fat cell differentiation | GO:0045444 | 160 | 0.052 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.051 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.050 | |
| developmental maturation | GO:0021700 | 193 | 0.049 | |
| epithelial tube formation | GO:0072175 | 130 | 0.049 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.047 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.046 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.046 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.046 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.045 | |
| muscle cell development | GO:0055001 | 133 | 0.045 | |
| angiogenesis | GO:0001525 | 201 | 0.045 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.045 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.044 | |
| cellular homeostasis | GO:0019725 | 240 | 0.044 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.044 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.044 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.044 | |
| skin development | GO:0043588 | 220 | 0.044 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.044 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.043 | |
| telencephalon development | GO:0021537 | 186 | 0.043 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.043 | |
| nuclear transport | GO:0051169 | 139 | 0.043 | |
| placenta development | GO:0001890 | 140 | 0.043 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.042 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.042 | |
| renal system development | GO:0072001 | 225 | 0.042 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.042 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.042 | |
| regionalization | GO:0003002 | 337 | 0.042 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.041 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.040 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.040 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.040 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.040 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.040 | |
| cation homeostasis | GO:0055080 | 212 | 0.040 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.040 | |
| gland development | GO:0048732 | 330 | 0.040 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.039 | |
| stem cell maintenance | GO:0019827 | 130 | 0.039 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.039 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.039 | |
| calcium ion transport | GO:0006816 | 159 | 0.039 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.039 | |
| spermatid differentiation | GO:0048515 | 115 | 0.038 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.038 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.038 | |
| muscle system process | GO:0003012 | 141 | 0.038 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.038 | |
| heart morphogenesis | GO:0003007 | 178 | 0.037 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.037 | |
| lung development | GO:0030324 | 164 | 0.037 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.037 | |
| protein ubiquitination | GO:0016567 | 171 | 0.037 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.037 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.036 | |
| adult behavior | GO:0030534 | 135 | 0.036 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.036 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.036 | |
| cell fate commitment | GO:0045165 | 210 | 0.035 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.035 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.035 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.035 | |
| defense response to other organism | GO:0098542 | 197 | 0.035 | |
| microtubule based process | GO:0007017 | 236 | 0.035 | |
| regulation of protein localization | GO:0032880 | 231 | 0.035 | |
| diencephalon development | GO:0021536 | 63 | 0.034 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.034 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.034 | |
| nephron development | GO:0072006 | 109 | 0.034 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.034 | |
| locomotory behavior | GO:0007626 | 195 | 0.034 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.034 | |
| hindbrain development | GO:0030902 | 128 | 0.034 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.034 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.034 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.033 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.033 | |
| steroid metabolic process | GO:0008202 | 119 | 0.033 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.032 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.032 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.032 | |
| male gamete generation | GO:0048232 | 285 | 0.032 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.032 | |
| response to acid chemical | GO:0001101 | 111 | 0.032 | |
| pallium development | GO:0021543 | 120 | 0.032 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.032 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.032 | |
| learning or memory | GO:0007611 | 148 | 0.032 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.032 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.032 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.032 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.032 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.031 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.031 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.031 | |
| endocrine system development | GO:0035270 | 98 | 0.031 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.031 | |
| gliogenesis | GO:0042063 | 141 | 0.031 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.031 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.031 | |
| regulation of cell migration | GO:0030334 | 219 | 0.031 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.031 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.031 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.031 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.031 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.031 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.030 | |
| glial cell differentiation | GO:0010001 | 131 | 0.030 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.030 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.030 | |
| regulation of neuron death | GO:1901214 | 134 | 0.030 | |
| membrane organization | GO:0061024 | 245 | 0.030 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.030 | |
| oxidation reduction process | GO:0055114 | 342 | 0.029 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.029 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.029 | |
| odontogenesis | GO:0042476 | 78 | 0.029 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.029 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.029 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.029 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.029 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.029 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.029 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.029 | |
| mesenchyme development | GO:0060485 | 152 | 0.028 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.028 | |
| spermatid development | GO:0007286 | 108 | 0.028 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.028 | |
| glial cell development | GO:0021782 | 54 | 0.028 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.028 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.028 | |
| kidney development | GO:0001822 | 213 | 0.028 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.027 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.027 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.027 | |
| mitochondrion organization | GO:0007005 | 134 | 0.027 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.027 | |
| male gonad development | GO:0008584 | 88 | 0.027 | |
| synaptic transmission | GO:0007268 | 329 | 0.027 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.027 | |
| sensory perception | GO:0007600 | 245 | 0.027 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.026 | |
| axonogenesis | GO:0007409 | 274 | 0.026 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.026 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.026 | |
| muscle contraction | GO:0006936 | 101 | 0.026 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.026 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.026 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.026 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.026 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.026 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.026 | |
| peptide secretion | GO:0002790 | 114 | 0.026 | |
| neural tube development | GO:0021915 | 160 | 0.026 | |
| forebrain development | GO:0030900 | 302 | 0.026 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.026 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.026 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.025 | |
| tissue homeostasis | GO:0001894 | 115 | 0.025 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.025 | |
| regulation of ion transport | GO:0043269 | 215 | 0.025 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.025 | |
| positive regulation of actin nucleation | GO:0051127 | 3 | 0.025 | |
| primary neural tube formation | GO:0014020 | 95 | 0.025 | |
| limbic system development | GO:0021761 | 72 | 0.025 | |
| epithelial cell development | GO:0002064 | 159 | 0.025 | |
| female sex differentiation | GO:0046660 | 84 | 0.025 | |
| blood circulation | GO:0008015 | 195 | 0.025 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.025 | |
| neural crest cell development | GO:0014032 | 48 | 0.025 | |
| glucose homeostasis | GO:0042593 | 128 | 0.025 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.025 | |
| cardiac chamber development | GO:0003205 | 108 | 0.025 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.024 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.024 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.024 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.024 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.024 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.024 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.024 | |
| cation transport | GO:0006812 | 399 | 0.024 | |
| stem cell proliferation | GO:0072089 | 117 | 0.024 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.024 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.024 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.023 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.023 | |
| heart contraction | GO:0060047 | 93 | 0.023 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.023 | |
| digestive tract development | GO:0048565 | 190 | 0.023 | |
| tube formation | GO:0035148 | 140 | 0.023 | |
| digestive system development | GO:0055123 | 200 | 0.023 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.023 | |
| response to oxidative stress | GO:0006979 | 123 | 0.023 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.023 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.023 | |
| protein localization to organelle | GO:0033365 | 185 | 0.023 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.023 | |
| protein processing | GO:0016485 | 163 | 0.023 | |
| protein import | GO:0017038 | 101 | 0.023 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.023 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.023 | |
| hair follicle development | GO:0001942 | 85 | 0.022 | |
| renal tubule development | GO:0061326 | 87 | 0.022 | |
| protein import into nucleus | GO:0006606 | 95 | 0.022 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.022 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.022 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.022 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.022 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.022 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.022 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.022 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.022 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.022 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.022 | |
| response to radiation | GO:0009314 | 165 | 0.021 | |
| axon ensheathment | GO:0008366 | 76 | 0.021 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.021 | |
| neuron migration | GO:0001764 | 122 | 0.021 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.021 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.021 | |
| nephron epithelium development | GO:0072009 | 92 | 0.021 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.021 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.021 | |
| regulation of protein transport | GO:0051223 | 163 | 0.021 | |
| chromatin modification | GO:0016568 | 187 | 0.021 | |
| neural crest cell differentiation | GO:0014033 | 54 | 0.021 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.021 | |
| multicellular organism growth | GO:0035264 | 161 | 0.021 | |
| spinal cord oligodendrocyte cell differentiation | GO:0021529 | 3 | 0.021 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.021 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.021 | |
| protein targeting | GO:0006605 | 143 | 0.021 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.021 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.020 | |
| female gonad development | GO:0008585 | 71 | 0.020 | |
| gonad development | GO:0008406 | 141 | 0.020 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.020 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.020 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.020 | |
| chemotaxis | GO:0006935 | 247 | 0.020 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.020 | |
| regulation of cell motility | GO:2000145 | 236 | 0.020 | |
| trophoblast giant cell differentiation | GO:0060707 | 15 | 0.020 | |
| cell adhesion | GO:0007155 | 329 | 0.020 | |
| hair cycle | GO:0042633 | 90 | 0.020 | |
| cerebral cortex development | GO:0021987 | 86 | 0.020 | |
| heart process | GO:0003015 | 94 | 0.020 | |
| organelle fission | GO:0048285 | 170 | 0.020 | |
| oviduct development | GO:0060066 | 3 | 0.019 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.019 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.019 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.019 | |
| tissue remodeling | GO:0048771 | 102 | 0.019 | |
| response to inorganic substance | GO:0010035 | 96 | 0.019 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.019 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.019 | |
| macromolecule methylation | GO:0043414 | 120 | 0.019 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.019 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.019 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.019 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.019 | |
| tube closure | GO:0060606 | 91 | 0.019 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.019 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.019 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.019 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.018 | |
| lateral inhibition | GO:0046331 | 1 | 0.018 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.018 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.018 | |
| inner ear receptor cell differentiation | GO:0060113 | 61 | 0.018 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.018 | |
| methylation | GO:0032259 | 134 | 0.018 | |
| mapk cascade | GO:0000165 | 281 | 0.018 | |
| limb morphogenesis | GO:0035108 | 149 | 0.018 | |
| protein maturation | GO:0051604 | 176 | 0.018 | |
| striated muscle contraction | GO:0006941 | 45 | 0.018 | |
| synapse organization | GO:0050808 | 125 | 0.018 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.018 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.018 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.017 | |
| somite development | GO:0061053 | 81 | 0.017 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.017 | |
| neural retina development | GO:0003407 | 41 | 0.017 | |
| biomineral tissue development | GO:0031214 | 64 | 0.017 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.017 | |
| regulation of cell activation | GO:0050865 | 289 | 0.017 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.017 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.017 | |
| germ cell development | GO:0007281 | 185 | 0.017 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.017 | |
| regulation of ossification | GO:0030278 | 112 | 0.017 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.017 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.017 | |
| fertilization | GO:0009566 | 127 | 0.017 | |
| hormone secretion | GO:0046879 | 128 | 0.017 | |
| female gamete generation | GO:0007292 | 74 | 0.017 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.017 | |
| b cell differentiation | GO:0030183 | 78 | 0.017 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.017 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.017 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.016 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.016 | |
| vasodilation | GO:0042311 | 28 | 0.016 | |
| connective tissue development | GO:0061448 | 179 | 0.016 | |
| pancreas development | GO:0031016 | 57 | 0.016 | |
| ear morphogenesis | GO:0042471 | 118 | 0.016 | |
| nuclear import | GO:0051170 | 95 | 0.016 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.016 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.016 | |
| protein localization to membrane | GO:0072657 | 108 | 0.016 | |
| regulation of actin nucleation | GO:0051125 | 4 | 0.016 | |
| single organism nuclear import | GO:1902593 | 95 | 0.016 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.016 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.016 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.016 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.016 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.016 | |
| chromatin organization | GO:0006325 | 206 | 0.016 | |
| endomembrane system organization | GO:0010256 | 147 | 0.016 | |
| myelination | GO:0042552 | 74 | 0.016 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.016 | |
| blastocyst development | GO:0001824 | 80 | 0.016 | |
| neuromuscular process | GO:0050905 | 99 | 0.016 | |
| mesonephros development | GO:0001823 | 97 | 0.016 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.016 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.016 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.015 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.015 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.015 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.015 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.015 | |
| spleen development | GO:0048536 | 39 | 0.015 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.015 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.015 | |
| midgut development | GO:0007494 | 4 | 0.015 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.015 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.015 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.015 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.015 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.015 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.015 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.015 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.015 | |
| regulation of system process | GO:0044057 | 200 | 0.015 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.015 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.015 | |
| response to peptide | GO:1901652 | 136 | 0.015 | |
| cellular response to peptide | GO:1901653 | 92 | 0.015 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.015 | |
| neuron death | GO:0070997 | 154 | 0.015 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.015 | |
| b cell activation | GO:0042113 | 161 | 0.015 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.015 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.015 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.015 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.015 | |
| gastrulation | GO:0007369 | 116 | 0.015 | |
| spermatogenesis | GO:0007283 | 284 | 0.015 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.015 | |
| regulation of translation | GO:0006417 | 71 | 0.015 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.015 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.015 | |
| protein acylation | GO:0043543 | 64 | 0.015 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.014 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.014 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.014 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.014 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.014 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.014 | |
| myoblast differentiation | GO:0045445 | 52 | 0.014 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.014 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.014 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.014 | |
| mechanoreceptor differentiation | GO:0042490 | 67 | 0.014 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.014 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.014 | |
| innate immune response | GO:0045087 | 157 | 0.014 | |
| tissue migration | GO:0090130 | 68 | 0.014 | |
| transmembrane transport | GO:0055085 | 412 | 0.014 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.014 | |
| molting cycle | GO:0042303 | 90 | 0.014 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.014 | |
| somitogenesis | GO:0001756 | 69 | 0.014 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.014 | |
| mesoderm development | GO:0007498 | 100 | 0.014 | |
| atp catabolic process | GO:0006200 | 55 | 0.014 | |
| rhythmic process | GO:0048511 | 174 | 0.014 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.014 | |
| response to nutrient levels | GO:0031667 | 109 | 0.014 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.014 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.014 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.014 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.014 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.014 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.014 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.014 | |
| segmentation | GO:0035282 | 93 | 0.014 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.014 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.014 | |
| hippocampus development | GO:0021766 | 52 | 0.014 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.014 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.014 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.014 | |
| nuclear division | GO:0000280 | 158 | 0.014 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.014 | |
| respiratory tube development | GO:0030323 | 167 | 0.013 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.013 | |
| negative regulation of growth | GO:0045926 | 99 | 0.013 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.013 | |
| germ line stem cell division | GO:0042078 | 2 | 0.013 | |
| retinal bipolar neuron differentiation | GO:0060040 | 5 | 0.013 | |
| sterol metabolic process | GO:0016125 | 58 | 0.013 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.013 | |
| ovulation cycle | GO:0042698 | 59 | 0.013 | |
| protein alkylation | GO:0008213 | 81 | 0.013 | |
| amide transport | GO:0042886 | 138 | 0.013 | |
| oocyte axis specification | GO:0007309 | 2 | 0.013 | |
| eosinophil migration | GO:0072677 | 3 | 0.013 | |
| lipid localization | GO:0010876 | 126 | 0.013 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.013 | |
| limb development | GO:0060173 | 166 | 0.013 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.013 | |
| inflammatory response | GO:0006954 | 244 | 0.013 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.013 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.013 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.013 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.013 | |
| neural crest cell migration | GO:0001755 | 32 | 0.013 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.013 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.013 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.013 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.013 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.013 | |
| embryonic placenta development | GO:0001892 | 98 | 0.013 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.013 | |
| regulation of defense response | GO:0031347 | 233 | 0.013 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.013 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.013 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.013 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.013 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.013 | |
